1 (Pyridostigmine Bromide Tablets Usp 30 mg 1)
Pyridostigmine Bromide Tablet
Product Images NDC 0115-2134
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 0115-2134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Pyridostigmine Bromide Tablets Usp 30 mg 2)
This is a prescription medication containing 30 mg pyridostigmine bromide intended for oral use. Pyridostigmine bromide is used to treat myasthenia gravis, a condition characterized by muscle weakness and fatigue. The tablets are hygroscopic and should be kept in a dry place with the silica gel enclosed. This package is child-resistant and should be stored at 20° to 25°C. The prescription should be preserved in a tight, light-resistant container and kept out of the reach of children. Distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
